LIPOCINE INC. Deferred Tax Liabilities, Property, Plant and Equipment
LIPOCINE INC. (LPCN) had Deferred Tax Liabilities, Property, Plant and Equipment of $6.22 thousand as of 2025-12-31, per its 10-K filed 2026-03-10.
Financial Statements › Notes › Income Taxes › Components of Deferred Tax Assets and Liabilities › Deferred Tax Liabilities, Net
us-gaap:DeferredTaxLiabilitiesPropertyPlantAndEquipment · last filed 2026-03-10
- 2025-12-31: Deferred Tax Liabilities, Property, Plant and Equipment $6.22K.
- 2024-12-31: Deferred Tax Liabilities, Property, Plant and Equipment $8.78K.
- 2023-12-31: Deferred Tax Liabilities, Property, Plant and Equipment $7.23K.
- 2022-12-31: Deferred Tax Liabilities, Property, Plant and Equipment $9.05K.
| Period end | Deferred Tax Liabilities, Property, Plant and Equipment |
|---|---|
| 2025-12-31 | $6.22K 10-K · filed 2026-03-10 |
| 2024-12-31 | $8.78K 10-K · filed 2026-03-10 |
| 2023-12-31 | $7.23K 10-K · filed 2025-03-13 |
| 2022-12-31 | $9.05K 10-K · filed 2024-03-07 |
| 2021-12-31 | $1.87K 10-K · filed 2023-03-10 |
| 2018-12-31 | $0.00 10-K · filed 2019-03-06 |
| 2017-12-31 | $3.16K 10-K · filed 2019-03-06 |
| 2016-12-31 | $4.11K 10-K · filed 2018-03-12 |
| 2015-12-31 | $3.64K 10-K · filed 2017-03-06 |
| 2014-12-31 | $2.90K 10-K · filed 2016-03-10 |
| 2013-12-31 | $4.07K 10-K · filed 2015-03-11 |
| 2012-12-31 | $3.40K 10-K · filed 2014-03-31 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| PALATIN TECHNOLOGIES INC (PTN) | United States | $0.017B | -5.36 |
| Allarity Therapeutics, Inc. (ALLR) | United States | $0.017B | -1.66 |
| Biofrontera Inc. (BFRI) | United States | $0.018B | -2.13 |
| Pasithea Therapeutics Corp. (KTTA) | United States | $0.017B | -0.81 |
| Rocket One Inc. (RKTO) | United States | $0.019B | |
| Korsana Biosciences, Inc. (CYCN) | United States | $0.016B | |
| Shuttle Pharmaceuticals Holdings, Inc. (SHPH) | United States | $0.019B | -0.31 |
| Citius Pharmaceuticals, Inc. (CTXR) | United States | $0.016B | -133.06 |
| Lantern Pharma Inc. (LTRN) | United States | $0.015B | -2.87 |
| Cellectar Biosciences, Inc. (CLRB) | United States | $0.020B | -1.03 |